Funding for this research was provided by:
novartis pharmaceuticals corporation
Received: 17 November 2021
Accepted: 4 May 2022
First Online: 3 June 2022
: This study was deemed exempt from oversight by the RTI International Institutional Review Board. Participants provided consent to participate.
: Not applicable, as data are anonymized.
: CR, NH, and AG are employees of RTI Health Solutions. DD and DC are employees of Novartis Pharmaceuticals.